Jump to content

Hereditary carrier: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
m Reverted edits by 121.45.21.80 (talk) to last version by Addbot
Line 2: Line 2:
A '''genetic carrier''' (or just '''carrier'''), is a person or other organism that has [[Genetics|inherited]] a [[Phenotype|genetic trait]] or [[mutation]], but who does not display that trait or show symptoms of the [[Genetic disease|disease]]. They are, however, able to [[Heredity|pass]] the [[gene]] onto their offspring, who may then express the gene. This phenomenon is a direct result of the [[Dominance_relationship#Recessive_allele|recessive]] nature of many genes.
A '''genetic carrier''' (or just '''carrier'''), is a person or other organism that has [[Genetics|inherited]] a [[Phenotype|genetic trait]] or [[mutation]], but who does not display that trait or show symptoms of the [[Genetic disease|disease]]. They are, however, able to [[Heredity|pass]] the [[gene]] onto their offspring, who may then express the gene. This phenomenon is a direct result of the [[Dominance_relationship#Recessive_allele|recessive]] nature of many genes.


For example, the daughters of Queen [[Victoria of the United Kingdom|Victoria]], the princesses Dermot and Beatrix, were carriers of the [[Sex linked|X-linked]] [[hemophilia]] gene (more precisely, an abnormal allele of a gene necessary to produce one of the blood clotting factors). Both had children who continued to pass the gene to succeeding generations of the royal houses of [[Spain]] and [[Russia]], into which they married. Males who carried the altered gene had hemophilia, while females simply passed it to about half of their children.
For example, the daughters of Queen [[Victoria of the United Kingdom|Victoria]], the princesses Alice and Beatrix, were carriers of the [[Sex linked|X-linked]] [[hemophilia]] gene (more precisely, an abnormal allele of a gene necessary to produce one of the blood clotting factors). Both had children who continued to pass the gene to succeeding generations of the royal houses of [[Spain]] and [[Russia]], into which they married. Males who carried the altered gene had hemophilia, while females simply passed it to about half of their children.


Up to 1 in 25 individuals of Northern European ancestry may be considered carriers of mutations that could lead to [[Cystic Fibrosis]]. The disease appears only when two of these carriers have children, as each pregnancy between them will have a 25% chance of producing a child with the disease. However, it is also thought that carriers may be more resistant to diarrhea during [[typhoid fever]] or [[cholera]], and are therefore not truly asymptomatic. This resistance leads to [[Heterozygote advantage|increased survival]] of the carriers, thereby increasing the frequency of the altered [[Cystic fibrosis transmembrane conductance regulator|genes]] in the population.
Up to 1 in 25 individuals of Northern European ancestry may be considered carriers of mutations that could lead to [[Cystic Fibrosis]]. The disease appears only when two of these carriers have children, as each pregnancy between them will have a 25% chance of producing a child with the disease. However, it is also thought that carriers may be more resistant to diarrhea during [[typhoid fever]] or [[cholera]], and are therefore not truly asymptomatic. This resistance leads to [[Heterozygote advantage|increased survival]] of the carriers, thereby increasing the frequency of the altered [[Cystic fibrosis transmembrane conductance regulator|genes]] in the population.

Revision as of 06:36, 21 May 2013

A genetic carrier (or just carrier), is a person or other organism that has inherited a genetic trait or mutation, but who does not display that trait or show symptoms of the disease. They are, however, able to pass the gene onto their offspring, who may then express the gene. This phenomenon is a direct result of the recessive nature of many genes.

For example, the daughters of Queen Victoria, the princesses Alice and Beatrix, were carriers of the X-linked hemophilia gene (more precisely, an abnormal allele of a gene necessary to produce one of the blood clotting factors). Both had children who continued to pass the gene to succeeding generations of the royal houses of Spain and Russia, into which they married. Males who carried the altered gene had hemophilia, while females simply passed it to about half of their children.

Up to 1 in 25 individuals of Northern European ancestry may be considered carriers of mutations that could lead to Cystic Fibrosis. The disease appears only when two of these carriers have children, as each pregnancy between them will have a 25% chance of producing a child with the disease. However, it is also thought that carriers may be more resistant to diarrhea during typhoid fever or cholera, and are therefore not truly asymptomatic. This resistance leads to increased survival of the carriers, thereby increasing the frequency of the altered genes in the population.

Genetic carrier testing can be used to tell if a person carries one or more mutations of the CF gene and how many copies of each mutation. The test looks at a person’s DNA (genetic material), which is taken from cells in a blood sample or from cells that are gently scraped from inside the mouth.

Although only about one of every 3,000 Caucasian newborns has CF, there are more than 1,000 known mutations of the gene that causes CF. Current tests look for the most common mutations.

The mutations screened by the test vary according to a person's race or ethnic group, or by the occurrence of CF already in the family. More than 10 million Americans, including one in 29 Caucasian Americans, are carriers of one mutation of the CF gene. In other races or ethnicities, one in 46 Hispanic Americans, one in 65 African Americans and one in 90 Asian Americans carry a mutation of the CF gene.